Mon, 14 Mar 2016 | DIVISION SALE
UK-based support services and construction company Interserve is considering offloading its profitable equipment services division RWD Kwikform.
The division has been placed under a strategic review and may well be sold by Interserve. RMD Kwikform currently accounts for around six per cent of the group’s turnover and a third of headline operating profit.
The announcement made recently by chief executive Adrian Ringrose, comes as Interserve reported pre-tax profits of £80 million (a rise of 28 per cent) and turnover of £3.2 billion (up 10 per cent) in 2015.
Mr Ringrose said: “Our performance in 2015 was good, resulting in 12 per cent operating profit growth in markets that continue to offer both opportunities and challenges.
“These issues were, however, partially offset in the year by strong performance in our building and fit-out businesses.
“In light of the changing shape of our portfolio over the last few years, we have started a strategic review of our equipment services business RMD Kwikform.”
RMD Kwikform’s revenue jumped from £195.5 million in 2014 to £211 million last year (a growth rate of eight per cent) and contributed £41.9 million to the group’s operating profit.
Mr Ringrose added: “Overall, we expect 2016 to be broadly steady compared to 2015 as underlying growth is restrained by the impact of a slower order intake following an election year and the impact of the National Living Wage.
“However, we expect to return to growth in 2017, underpinned by our strong positions in attractive markets.”
See the Business Sale Report guide to Searching for an acquisition opportunity.
This unique and renowned freehold bar and restaurant in the heart of York City Centre offers over 250 covers across its spacious interior, pavement seating, and a rare rooftop terrace.
FREEHOLD
A well established and strongly profitable engineering business, located in the Midlands. The company will be an attractive acquisition for both a larger trade buyer and also those looking for a stable engineering business.
This European pharmacy manufacturer specialises in providing custom clinical trial batches for leading pharmacy companies across the continent, playing a crucial role in their R&D efforts.
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.